ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

97 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-01-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Spain, family physician are currently recommended to prescribe an unsupervised walking program to their coronary heart disease (CHD) patients as a part of their cardiac rehabilitation program. However, there are a few family physicians who provide their CHD patients with supervised exercise (30 minutes of pedaling on an stationary bicycle at 60-85% of the peak heart rate (HR) attained at the maximal or symptom limited treadmill test, 3 times a week) at their primary care health centers, thinking that these patients improve their functional capacity, quality of life, and the control of cardiovascular risk factors, more than walking because they can not achieve the ideal exercise intensity for maximal benefits by walking. This study has been designed to investigate if CHD patients get more health benefits with the supervised exercise program at the health center than with the unsupervised walking program.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors

NCT00758810

Myocardial Infarction Acute Coronary Syndrome

COMPLETED

Exercise for Patients With Heart Failure in Primary Care: the EFICAR

NCT01033591

Heart Failure

UNKNOWN PHASE3

Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.

NCT05927363

Myocardial Infarction

COMPLETED NA

Training Programme in Physical Activity

NCT03717363

Cardiovascular Risk Factor Cardiovascular Disease

COMPLETED NA

Outpatient Cardiac Tele-Rehabilitation in a Public Sports Center

NCT04121702

Acute Coronary Syndrome Cardiac Rehabilitation Telerehabilitation +3 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to obtain the maximal health benefits, CHD patients have to attain an exercise intensity between 60 and 85% of the maximal or symptom-limited heart rate (HR). This is not currently attained by the patients who are prescribed an unsupervised walking program.

The OBJECTIVE of this randomized clinical trial is to investigate if CHD patients improve their functional capacity and quality of life more, and control their cardiovascular risk factors better, by coming to their health centers to pedal during 30 minutes on an stationary bicycle , 3 or more times a week, with a HR monitor which makes sure that they attain HRs within the prescribed interval, and supervised by health personal, than by walking without supervision. For that purpose, low risk CHD patients from 11 Spanish health centers will be randomly assigned to a supervised exercise group (ESCAP) or to another unsupervised walking group (control). Both groups will be also provided with health education and the corresponding treatment for cardiovascular risk factor control and complication prevention by their family physicians. The average changes observed in the two groups will be compared, on the basis of intention to treat through analysis of covariance. We will use mixed-effect models to take into account intra-patients and intra-center correlation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Secondary prevention program for coronary heart disease

Group Type ACTIVE_COMPARATOR

Secondary prevention program for coronary heart disease

Intervention Type BEHAVIORAL

Secondary prevention program for coronary heart disease

Supervised exercise

Group Type EXPERIMENTAL

Supervised exercise on a stationary bicycle, 3-5 days a week

Intervention Type BEHAVIORAL

Supervised exercise on a stationary bicycle, 3-5 days a week, plus a secondary prevention program for coronary heart disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supervised exercise on a stationary bicycle, 3-5 days a week

Supervised exercise on a stationary bicycle, 3-5 days a week, plus a secondary prevention program for coronary heart disease

Intervention Type BEHAVIORAL

Secondary prevention program for coronary heart disease

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Coronary heart disease low risk patients
* Under 80 years old

Exclusion Criteria

* 80 years of age and over
* Patients included in cardiac rehabilitation programs
* Moderate and high risk patients
* Patients with handicaps for exercising
* Patients unable to attend the supervised exercise sessions
* Unstable angina
* Uncontrolled atrial ventricular arrhythmias
* Third degree AV block (without pacemaker)
* Uncompensated congestive heart failure
* Severe aortic stenosis
* Suspected or known dissecting aneurysm
* Active myocarditis or pericarditis
* Thrombophlebitis
* Recent embolism
* Acute systemic illness or fever
* Significant emotional distress (psychosis)
* Orthostatic blood pressure drop of \>20 mm Hg with symptoms
* Uncontrolled sinus tachycardia
* Resting ST segment displacement (\>2 mm)
* Uncontrolled diabetes (resting blood glucose \>400 mg/dl)
* Other metabolic problems such as acute thyroiditis, hypo or hyperkalemia, hypovolemia, etc.
* Resting SBP\>200 mm Hg or resting DBP\>110 mm Hg

Minimum Eligible Age

20 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No